About DoseMe
DoseMe is a company based in Houston (United States) founded in 2014 by Robert McLeay was acquired by Fairlong Capital in January 2023. DoseMe offers products and services including DoseMeRx Platform, Vancomycin Dosing Calculator, and Analytics and Integrations. DoseMe operates in a competitive market with competitors including Ivenix, Hygieia, Assurex Health, InsightRx and GenXys, among others.
- Headquarter Houston, United States
- Founders Robert McLeay
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Doseme Pty Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
AnewHealth
& 1 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DoseMe
DoseMe offers a comprehensive portfolio of products and services, including DoseMeRx Platform, Vancomycin Dosing Calculator, and Analytics and Integrations.
Bayesian tool for accurate drug dosing and patient outcome optimization
Specialized calculator for precise vancomycin dose adjustments
Web-based tools for data analysis and system integration in healthcare
People of DoseMe
Unlock access to complete
Funding Insights of DoseMe
Investors in DoseMe
DoseMe has secured backing from 2 investors. Prominent investors backing the company include AnewHealth and Fairlong Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cloud-based medication risk optimization solutions are provided for healthcare organizations.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by DoseMe
Financial Statements - DoseMe
Doseme Comparisons
Competitors of DoseMe
DoseMe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ivenix, Hygieia, Assurex Health, InsightRx and GenXys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Infusion management systems are developed with wireless web-based architecture.
|
|
| domain | founded_year | HQ Location |
Insulin dosage guidance for diabetes is provided via handheld devices.
|
|
| domain | founded_year | HQ Location |
Personalized medication for neuropsychiatric conditions is guided by pharmacogenomics.
|
|
| domain | founded_year | HQ Location |
Precision dosing is optimized via machine learning and patient data.
|
|
| domain | founded_year | HQ Location |
Provider of pharmacogenetic testing and a medication decision support system
|
|
| domain | founded_year | HQ Location |
Personalized supplement recommendations are generated from genomic and health data.
|
Latest news on Doseme
Frequently Asked Questions about DoseMe
DoseMe was founded in 2014.
DoseMe is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Charles Cornish is the current CEO of DoseMe.
DoseMe was founded in 2014 in Houston, United States, within the precision medicine sector. A platform is offered to doctors, enabling real-time pharmacokinetic measurements via electronic health records. Drug doses are calculated and compared, with customizations made for individual patients. HIPAA compliance is maintained, and integration with EHR systems is supported to aid drug optimization.
DoseMe's top competitors include Assurex Health, Ivenix and Hygieia.
DoseMe offers DoseMeRx Platform, Vancomycin Dosing Calculator, and Analytics and Integrations.
DoseMe has 2 investors. Key investors include AnewHealth, and Fairlong Capital.